AIDS Research Program News

NIH Radio interviews BC-CfE director Dr. Julio Montaner on the importance of bringing HIV treatment to under-serviced populations, including injection drug users.

In a world where rhetoric often outpaces action, Prime Minister Stephen Harper's brazen hypocrisy about following through – and paying for – our nation's global health commitments stands out.

Three studies presented at CROI give the first indication that expanded testing and treatment are viable and can help reduce the spread of the disease in high-income countries with overall low prevalence (though specific areas may have pockets of high prevalence).

With Britain leading the way, G8 leaders pledged at the U.K.‐led Gleneagles G8 Summit in 2005 to achieve universal access to HIV prevention, treatment and care by 2010. Significant progress has been made in some areas yet, as the universal access pledge comes due, only one‐third of people in need of HIV treatment worldwide receive it, while more than 10 million more people in urgent need of life‐saving HIV treatment wait.

A global summit on HIV was hosted by LifeSciences British Columbia, the BC Centre of Excellence in HIV/AIDS, and the University of British Columbia (UBC) on 26 February against the backdrop of the 2010 Olympic Games.

The controversial notion of treatment as prevention has suddenly become one of the hottest issues in the science of the disease

Cutting-edge AIDS medications have lengthened patients' lives and given many a better existence than they would have had 10 years ago, but these advances have helped push the disease out of mainstream consciousness.

Vancouver's gay community is not immune to a drug-resistant strain of potentially deadly bacteria that U.S. researchers say is on the rise outside of hospitals south of the border, according to a B.C. medical expert.